Article | April 19, 2021 Bridging The Knowledge Gap On Digital Clinical Measures: A Technology Partner's Perspective On The âThe Playbook' By Jeremy Wyatt, ActiGraph CEO ActiGraph was one of the very first commercial providers of wearable motion-sensing technology, with legacy products dating back to the 1990s. In the years since, innovations in hardware technology, cloud storage and computing, and system interoperability have vastly expanded the capabilities of wearable motion sensors, adding many new layers of complexity in the process. Although this type of technology has been used and validated in academic research for over twenty years, it’s still relatively new within the world of clinical drug development. And while a myriad of industry publications and resources provide guidance around various aspects of wearables and digital measures, there is still a large knowledge gap when it comes to actual implementation of digital measures in a clinical drug trial.